|
Neoadjuvant chemoradiotherapy with capecitabine in locally advanced rectal cancer: Analysis of prognostic factors. |
|
|
Honoraria - Astellas Pharma |
Consulting or Advisory Role - Abbott |
|
Travel, Accommodations, Expenses - Janssen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma |
|
|
Travel, Accommodations, Expenses - Astellas Pharma |
|
|
Honoraria - Astellas Pharma |
Speakers' Bureau - Takeda |
|
|
Speakers' Bureau - Ferrer; Kyowa Hakko Kirin |
|
|
Honoraria - Astellas Pharma |
Speakers' Bureau - Abbott; Janssen |
|
|
Travel, Accommodations, Expenses - Acraf |
|
|
|
Travel, Accommodations, Expenses - Bayer |
|
|
Consulting or Advisory Role - 3D Matrix |
Speakers' Bureau - Boston Scientific |
Research Funding - Norgine |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Abbott |
Travel, Accommodations, Expenses - Acraf |
|
|
No Relationships to Disclose |